Weill Medical College Of Cornell University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1865-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://weill.cornell.edu
Clinical Trials
849
Active:38
Completed:419
Trial Phases
6 Phases
Early Phase 1:13
Phase 1:91
Phase 2:127
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (660 trials with phase data)• Click on a phase to view related trials
Not Applicable
321 (48.6%)Phase 2
127 (19.2%)Phase 1
91 (13.8%)Phase 4
79 (12.0%)Phase 3
29 (4.4%)Early Phase 1
13 (2.0%)Centralized Lung Cancer Screening Engagement in At-Risk Populations
Not Applicable
Not yet recruiting
- Conditions
- Lung Cancer Screening
- First Posted Date
- 2025-10-14
- Last Posted Date
- 2025-10-14
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 2000
- Registration Number
- NCT07216144
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
Technology-Based Intervention Usability and Pilot Testing
Not Applicable
Not yet recruiting
- Conditions
- DementiaElder AbuseElder Neglect
- First Posted Date
- 2025-08-28
- Last Posted Date
- 2025-09-25
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 40
- Registration Number
- NCT07146581
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
STICH3C Cardiac Magnetic Resonance Observational Study
Recruiting
- Conditions
- Ischemic Left Ventricle Systolic DysfunctionMultivessel Coronary Artery Disease
- First Posted Date
- 2025-08-21
- Last Posted Date
- 2025-08-21
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 200
- Registration Number
- NCT07133984
- Locations
- 🇺🇸
NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States
🇺🇸New York Presbyterian - Queens, Flushing, New York, United States
🇺🇸Weill Cornell Medicine/NewYork Presbyterian Hospital, New York, New York, United States
Use of Gocovri to Improve Disability Due to Radiation Encephalopathy
Not Applicable
Not yet recruiting
- Conditions
- Radiation Encephalopathy
- Interventions
- Drug: Gocovri (extended-release amantidine)
- First Posted Date
- 2025-08-15
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 24
- Registration Number
- NCT07125222
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
Patient-engaged Development and Testing of Educational Content on Side Effects of Statins
Not Applicable
- Conditions
- Dyslipidemia
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-09-16
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 30
- Registration Number
- NCT07094412
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 170
- Next
News
No news found